VBIO · Valion Bio Inc
United States · RS rating 30 · As of 2026-11-03
| Price | 0.53 USD |
|---|---|
| 1-day change | -0.0% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 2 / 96 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 30 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +2.7% |
| Sales growth Q/Q | -306.9% |
| Distance from 52-week high | +85.1% |
| Market cap (USD) | $2.8M |